Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1119)
BridgeBio Pharma, Inc. (BBIO)
Ellis Andrea — Director
Shares
64,921
Price
$64.87
Total Value
$4.21M
Shares Held After
18,589
% of Holdings
77.7%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
13,941
Price
$36.33
Total Value
$506.46K
Shares Held After
131,196
% of Holdings
9.6%
VERACYTE, INC. (VCYT)
Chambers Rebecca — Chief Financial Officer
Shares
4,400
Price
$35.55
Total Value
$156.41K
Shares Held After
145,137
% of Holdings
2.9%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
265
Price
$325.67
Total Value
$86.30K
Shares Held After
95,695
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
345
Price
$324.88
Total Value
$112.08K
Shares Held After
95,960
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
973
Price
$323.84
Total Value
$315.10K
Shares Held After
96,305
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
444
Price
$323.01
Total Value
$143.42K
Shares Held After
97,278
% of Holdings
0.5%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
368
Price
$321.82
Total Value
$118.43K
Shares Held After
97,722
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
274
Price
$320.81
Total Value
$87.90K
Shares Held After
98,090
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
129
Price
$320.01
Total Value
$41.28K
Shares Held After
98,364
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Greenstreet Yvonne — Director
Shares
135
Price
$319.03
Total Value
$43.07K
Shares Held After
98,493
% of Holdings
0.1%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
208
Price
$325.67
Total Value
$67.74K
Shares Held After
34,297
% of Holdings
0.6%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
272
Price
$324.88
Total Value
$88.37K
Shares Held After
34,505
% of Holdings
0.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
767
Price
$323.84
Total Value
$248.39K
Shares Held After
34,777
% of Holdings
2.2%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
350
Price
$323.01
Total Value
$113.05K
Shares Held After
35,544
% of Holdings
1.0%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
289
Price
$321.82
Total Value
$93.01K
Shares Held After
35,894
% of Holdings
0.8%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
215
Price
$320.81
Total Value
$68.97K
Shares Held After
36,183
% of Holdings
0.6%
uniQure N.V. (QURE)
Abi-Saab Walid — Chief Medical Officer
Shares
808
Price
$9.06
Total Value
$7.32K
Shares Held After
189,669
% of Holdings
0.4%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
102
Price
$320.01
Total Value
$32.64K
Shares Held After
36,398
% of Holdings
0.3%
ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Tanguler Tolga — EVP, Chief Commercial Officer
Shares
106
Price
$319.03
Total Value
$33.82K
Shares Held After
36,500
% of Holdings
0.3%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
8,233
Price
$35.99
Total Value
$296.35K
Shares Held After
2,231
% of Holdings
78.7%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
201
Price
$80.00
Total Value
$16.08K
Shares Held After
4,347
% of Holdings
4.4%
IONIS PHARMACEUTICALS INC (IONS)
Baroldi Joseph — EVP, Chief Business Officer
Shares
238
Price
$80.00
Total Value
$19.04K
Shares Held After
4,347
% of Holdings
5.2%
IONIS PHARMACEUTICALS INC (IONS)
LOSCALZO JOSEPH — Director
Shares
200
Price
$80.00
Total Value
$16.00K
Shares Held After
36,330
% of Holdings
0.5%
Monte Rosa Therapeutics, Inc. (GLUE)
Dunn Edmund — Principal Accounting Officer
Shares
139
Price
$17.96
Total Value
$2.50K
Shares Held After
22,554
% of Holdings
0.6%
Nautilus Biotechnology, Inc. (NAUT)
Patel Sujal M — Director
Shares
25,000
Price
$2.61
Total Value
$65.24K
Shares Held After
10,366,721
% of Holdings
0.2%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
200
Price
$73.26
Total Value
$14.65K
Shares Held After
209,773
% of Holdings
0.1%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
2,075
Price
$71.98
Total Value
$149.36K
Shares Held After
209,973
% of Holdings
1.0%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
3,225
Price
$70.33
Total Value
$226.81K
Shares Held After
212,048
% of Holdings
1.5%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
2,631
Price
$18.73
Total Value
$49.29K
Shares Held After
339,392
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
3,413
Price
$208.80
Total Value
$712.62K
Shares Held After
21,662
% of Holdings
13.6%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
2,457
Price
$207.91
Total Value
$510.82K
Shares Held After
25,075
% of Holdings
8.9%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
1,588
Price
$206.89
Total Value
$328.54K
Shares Held After
27,532
% of Holdings
5.5%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
1,457
Price
$205.79
Total Value
$299.84K
Shares Held After
29,120
% of Holdings
4.8%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
743
Price
$204.74
Total Value
$152.13K
Shares Held After
30,577
% of Holdings
2.4%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
668
Price
$203.63
Total Value
$136.02K
Shares Held After
31,320
% of Holdings
2.1%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
697
Price
$202.79
Total Value
$141.34K
Shares Held After
31,988
% of Holdings
2.1%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
950
Price
$201.73
Total Value
$191.64K
Shares Held After
32,685
% of Holdings
2.8%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
698
Price
$201.09
Total Value
$140.36K
Shares Held After
33,635
% of Holdings
2.0%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
53
Price
$200.08
Total Value
$10.60K
Shares Held After
34,333
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
699
Price
$198.71
Total Value
$138.89K
Shares Held After
34,386
% of Holdings
2.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,142
Price
$208.87
Total Value
$238.53K
Shares Held After
36,869
% of Holdings
3.0%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
1,446
Price
$208.12
Total Value
$300.94K
Shares Held After
38,011
% of Holdings
3.7%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
612
Price
$207.01
Total Value
$126.69K
Shares Held After
39,457
% of Holdings
1.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
340
Price
$206.37
Total Value
$70.16K
Shares Held After
40,069
% of Holdings
0.8%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
460
Price
$205.18
Total Value
$94.38K
Shares Held After
40,409
% of Holdings
1.1%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
200
Price
$204.17
Total Value
$40.83K
Shares Held After
40,869
% of Holdings
0.5%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
300
Price
$201.70
Total Value
$60.51K
Shares Held After
41,069
% of Holdings
0.7%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
93
Price
$200.62
Total Value
$18.66K
Shares Held After
41,369
% of Holdings
0.2%
LIGAND PHARMACEUTICALS INC (LGND)
Reardon Andrew — CLO & Secretary
Shares
207
Price
$199.96
Total Value
$41.39K
Shares Held After
41,462
% of Holdings
0.5%
Showing 651–700 of 1119 transactions (page 14 of 23)